BACKGROUND: Asthma is a complex-trait disease caused by complicated interactions among multiple genetic and environmental risk factors. The clinical symptoms of asthma, such as periodic airway obstruction, hyperresponsiveness and mucus hypersecretion, are mediated by acute and chronic bronchial inflammation. METHODS: To better understand the mechanisms by which allergen-induced acute inflammation leads to chronic asthma accompanied by irreversible airway remodeling, we analyzed time course transcriptional responses in the lungs of model mice that were exposed to aerosolized ovalbumin for up to 9 weeks after an initial sensitization. RESULTS: We observed increased levels of total plasma IgE and histological changes in lung tissues from the ovalbumin-treated mice, which is consistent with the typical inflammatory phenotypes of asthma pathogenesis. Our oligonucleotide microarray analyses revealed a total of 776 differentially expressed genes induced by antigenic challenge (> or =1.5-fold change, p < 0.05). Of these genes, most of the immune-responsive genes were transiently up-regulated in the early phase of the allergen treatment (within a week) with a concomitant up-regulation of genes involved in mucus production. These genes were not differentially regulated in the mice challenged for a longer period of time (up to 6 weeks). We also identified some of the genes implicated in extracellular matrix remodeling, for which the time course expression did not necessarily coincide with the expression patterns of immune-responsive genes. CONCLUSION: Our data suggest that there is a complex interregulatory genetic network associated with the structural changes that accompany the progression of the allergic inflammatory reaction in chronic asthma. Copyright 2007 S. Karger AG, Basel.
BACKGROUND:Asthma is a complex-trait disease caused by complicated interactions among multiple genetic and environmental risk factors. The clinical symptoms of asthma, such as periodic airway obstruction, hyperresponsiveness and mucus hypersecretion, are mediated by acute and chronic bronchial inflammation. METHODS: To better understand the mechanisms by which allergen-induced acute inflammation leads to chronic asthma accompanied by irreversible airway remodeling, we analyzed time course transcriptional responses in the lungs of model mice that were exposed to aerosolized ovalbumin for up to 9 weeks after an initial sensitization. RESULTS: We observed increased levels of total plasma IgE and histological changes in lung tissues from the ovalbumin-treated mice, which is consistent with the typical inflammatory phenotypes of asthma pathogenesis. Our oligonucleotide microarray analyses revealed a total of 776 differentially expressed genes induced by antigenic challenge (> or =1.5-fold change, p < 0.05). Of these genes, most of the immune-responsive genes were transiently up-regulated in the early phase of the allergen treatment (within a week) with a concomitant up-regulation of genes involved in mucus production. These genes were not differentially regulated in the mice challenged for a longer period of time (up to 6 weeks). We also identified some of the genes implicated in extracellular matrix remodeling, for which the time course expression did not necessarily coincide with the expression patterns of immune-responsive genes. CONCLUSION: Our data suggest that there is a complex interregulatory genetic network associated with the structural changes that accompany the progression of the allergic inflammatory reaction in chronic asthma. Copyright 2007 S. Karger AG, Basel.
Authors: Alexander R Abbas; Janet K Jackman; Sherron L Bullens; Sarah M Davis; David F Choy; Grazyna Fedorowicz; Martha Tan; Bao-Tran Truong; Y Gloria Meng; Lauri Diehl; Lisa A Miller; Edward S Schelegle; Dallas M Hyde; Hilary F Clark; Zora Modrusan; Joseph R Arron; Lawren C Wu Journal: Am J Pathol Date: 2011-08-03 Impact factor: 4.307
Authors: Samir N P Kelada; Mark S Wilson; Urraca Tavarez; Kari Kubalanza; Bhavesh Borate; Greg S Whitehead; Shuichiro Maruoka; Michelle G Roy; Michelle Olive; Danielle E Carpenter; David M Brass; Thomas A Wynn; Donald N Cook; Christopher M Evans; David A Schwartz; Francis S Collins Journal: Am J Respir Cell Mol Biol Date: 2011-03-04 Impact factor: 6.914
Authors: Glenn P Dorsam; Scott A Hoselton; Ashley R Sandy; Amali E Samarasinghe; Emilie E Vomhof-Dekrey; Sheri T Dorsam; Jane M Schuh Journal: Microbiol Immunol Date: 2010-09 Impact factor: 1.955